Stay Updated with the Latest Ten Sixty Four Limited X64.AX News in Real Time
Find X64.AX news now at Meyka AI. Stay informed with the latest Ten Sixty Four Limited stocks updates, including price news, market analysis, and expert insights.
Daniel Koch hospitalized with tick-borne meningitis despite vaccination—July 9
Former Swiss BAG chief Daniel Koch hospitalized with FSME meningitis despite vaccination. Swiss immunization schedule offers 92% protection but may lag Germany and Austria’s booster protocols.
Australia’s New 30% Capital Gains Tax Hits Low-Income Earners From July 2027
Australia’s capital gains tax overhaul from July 2027 replaces the 50% discount with inflation indexing and a 30% minimum tax rate, affecting property and share investors.
Tesla Stock Rises on SpaceX Merger Buzz; RBC Lifts Target to $500—July 8
Tesla stock rises on SpaceX merger speculation. RBC raises price target to $500 with 24% upside. JPMorgan flags China regulatory risks as key hurdle.
FTSE 100 Plunges 1.7% on July 8 as Trump Ends Iran Deal
FTSE 100 fell 1.7% to 10,489 points on July 8 after Trump ended Iran ceasefire talks. Oil jumped 5.4%, energy stocks rose, but miners and financials fell amid geopolitical uncertainty.
Ruth Ellis Granted Posthumous Pardon on July 9, 2026
Ruth Ellis, hanged in 1955 for killing her abusive partner, receives conditional pardon from King Charles. Death sentence replaced with life imprisonment after evidence of sustained abuse was ignored at trial.
Air Canada Names Anko Van der Werff as New CEO on July 8, 2026
Air Canada names Anko Van der Werff, Scandinavian Airlines CEO with 25 years of aviation experience and fluency in French, as new leader starting January 2027.
Rocket Lab Stock Jumps on $8B Iridium Deal and Morgan Stanley Bull Case—July 8
Rocket Lab to buy Iridium for $8B. Morgan Stanley sets bull target at $293. RKLB stock down 17% this week but up 115% over 12 months. Deal closes mid-2027.
Kalyan Jewellers Stock Bounces 5% on Citi Buy Rating Despite Q1 Miss
Kalyan Jewellers stock rebounds 5% to ₹374 on Citi’s Buy rating and ₹750 price target, signaling 111% upside despite Q1 revenue missing forecasts. Meyka grades the stock B+.
Swiss Doctors Threaten Strike Over New Salary Cap Starting January 2027
Swiss doctors threaten strike over new billing cap limiting them to 1,577 points per day starting January 2027. The measure aims to control healthcare costs.